Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

HERV-W envelope protein inhibits oligodendroglial precursor cell differentiation.
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.
The Impact of Lesion In-Painting and Registration Methods on Voxel-Based Morphometry in Detecting Regional Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
Memory rehabilitation for people with multiple sclerosis.
A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patients.
Phenytoin (Dilantin) and acupuncture therapy in the treatment of intractable oral and facial pain.
Demyelination: the role of reactive oxygen and nitrogen species.
FDA warns about seizures linked to MS drug
Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
The little compound that could: how phenytoin changed drug discovery and development.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.
3D models of human ERα and ERβ complexed with coumestrol.
Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis.
Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).
[Epidemiology of multiple sclerosis in the Primosky Krai and Far East regions.]
Physiopathology of symptoms and signs in multiple sclerosis.
Anejaculatory infertility due to multiple sclerosis.
Autoimmune myelopathies.

Pages